These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 24652042)

  • 1. Epigenetics of multiple sclerosis: an updated review.
    Küçükali Cİ; Kürtüncü M; Çoban A; Çebi M; Tüzün E
    Neuromolecular Med; 2015 Jun; 17(2):83-96. PubMed ID: 24652042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic Modifications and Therapy in Multiple Sclerosis.
    Aslani S; Jafari N; Javan MR; Karami J; Ahmadi M; Jafarnejad M
    Neuromolecular Med; 2017 Mar; 19(1):11-23. PubMed ID: 27382982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic changes in patients with multiple sclerosis.
    Koch MW; Metz LM; Kovalchuk O
    Nat Rev Neurol; 2013 Jan; 9(1):35-43. PubMed ID: 23165337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The epigenetic mechanism for discordance of autoimmunity in monozygotic twins.
    Xiang Z; Yang Y; Chang C; Lu Q
    J Autoimmun; 2017 Sep; 83():43-50. PubMed ID: 28412046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin D and multiple sclerosis: An update.
    Pierrot-Deseilligny C; Souberbielle JC
    Mult Scler Relat Disord; 2017 May; 14():35-45. PubMed ID: 28619429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Updated Review of Epigenetic-Related Mechanisms and their Contribution to Multiple Sclerosis Disease.
    Eslahi M; Nematbakhsh N; Dastmalchi N; Teimourian S; Safaralizadeh R
    CNS Neurol Disord Drug Targets; 2023; 22(3):381-393. PubMed ID: 35043771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Genetic and Epigenetic Basis of Multiple Sclerosis.
    Hojati Z
    Adv Exp Med Biol; 2017; 958():65-90. PubMed ID: 28093709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic imprinting: A missing piece of the Multiple Sclerosis puzzle?
    Ruhrmann S; Stridh P; Kular L; Jagodic M
    Int J Biochem Cell Biol; 2015 Oct; 67():49-57. PubMed ID: 26002250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic changes in neurology: DNA methylation in multiple sclerosis.
    Iridoy Zulet M; Pulido Fontes L; Ayuso Blanco T; Lacruz Bescos F; Mendioroz Iriarte M
    Neurologia; 2017 Sep; 32(7):463-468. PubMed ID: 25976949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic mechanisms in multiple sclerosis and the major histocompatibility complex (MHC).
    Burrell AM; Handel AE; Ramagopalan SV; Ebers GC; Morahan JM
    Discov Med; 2011 Mar; 11(58):187-96. PubMed ID: 21447278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetics in Multiple Sclerosis: Molecular Mechanisms and Dietary Intervention.
    Rito Y; Torre-Villalvazo I; Flores J; Rivas V; Corona T
    Cent Nerv Syst Agents Med Chem; 2018 Jan; 18(1):8-15. PubMed ID: 26915659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetics in Multiple Sclerosis.
    Chan VS
    Adv Exp Med Biol; 2020; 1253():309-374. PubMed ID: 32445101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The critical role of epigenetics in systemic lupus erythematosus and autoimmunity.
    Long H; Yin H; Wang L; Gershwin ME; Lu Q
    J Autoimmun; 2016 Nov; 74():118-138. PubMed ID: 27396525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional genomics analysis of vitamin D effects on CD4+ T cells in vivo in experimental autoimmune encephalomyelitis ‬.
    Zeitelhofer M; Adzemovic MZ; Gomez-Cabrero D; Bergman P; Hochmeister S; N'diaye M; Paulson A; Ruhrmann S; Almgren M; Tegnér JN; Ekström TJ; Guerreiro-Cacais AO; Jagodic M
    Proc Natl Acad Sci U S A; 2017 Feb; 114(9):E1678-E1687. PubMed ID: 28196884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic research in multiple sclerosis: progress, challenges, and opportunities.
    Zheleznyakova GY; Piket E; Marabita F; Pahlevan Kakhki M; Ewing E; Ruhrmann S; Needhamsen M; Jagodic M; Kular L
    Physiol Genomics; 2017 Sep; 49(9):447-461. PubMed ID: 28754822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DQB1*0602 rather than DRB1*1501 confers susceptibility to multiple sclerosis-like disease induced by proteolipid protein (PLP).
    Kaushansky N; Altmann DM; David CS; Lassmann H; Ben-Nun A
    J Neuroinflammation; 2012 Feb; 9():29. PubMed ID: 22316121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic insights into multiple sclerosis disease progression.
    Kular L; Jagodic M
    J Intern Med; 2020 Jul; 288(1):82-102. PubMed ID: 32614160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetics and miRNAs in the diagnosis and treatment of multiple sclerosis.
    Koch MW; Metz LM; Kovalchuk O
    Trends Mol Med; 2013 Jan; 19(1):23-30. PubMed ID: 23153574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA DR2b-binding peptides from human endogenous retrovirus envelope, Epstein-Barr virus and brain proteins in the context of molecular mimicry in multiple sclerosis.
    Ramasamy R; Mohammed F; Meier UC
    Immunol Lett; 2020 Jan; 217():15-24. PubMed ID: 31689443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome, epigenome and RNA sequences of monozygotic twins discordant for multiple sclerosis.
    Baranzini SE; Mudge J; van Velkinburgh JC; Khankhanian P; Khrebtukova I; Miller NA; Zhang L; Farmer AD; Bell CJ; Kim RW; May GD; Woodward JE; Caillier SJ; McElroy JP; Gomez R; Pando MJ; Clendenen LE; Ganusova EE; Schilkey FD; Ramaraj T; Khan OA; Huntley JJ; Luo S; Kwok PY; Wu TD; Schroth GP; Oksenberg JR; Hauser SL; Kingsmore SF
    Nature; 2010 Apr; 464(7293):1351-6. PubMed ID: 20428171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.